CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2 KEY BENEFITS

1.1.1. Secondary research
1.1.2. Primary research
1.1.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top Winning Strategies

3.2.2.1. Top Winning Strategies, By Year, 2014-2017*
3.2.2.2. Top Winning Strategies, By Development, 2014-2017* (%)
3.2.2.3. Top Winning Strategies, By Company, 2014-2017*

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. MARKET SHARE ANALYSIS, 2016
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Extended durability of implantable cardiac monitors
3.5.1.2. Less hospital stay and fewer hospital readmission
3.5.1.3. Rise in incidence of atrial fibrillation, myocardial infraction, and arrhythmias

3.5.2. Restraints

3.5.2.1. Availability of alternative mode of treatment
3.5.2.2. High cost of implantable cardiac monitors

3.5.3. Opportunity

3.5.3.1. Increase in awareness about devices and treatment options for cardiac disorders

CHAPTER 4 IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CARDIAC ARRHYTHMIAS

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast by region
4.2.1. Market size and forecast by country

4.3. ATRIAL FIBRILLATION

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast by region
4.3.3. Market size and forecast by country

4.4. EPILEPSY & UNEXPLAINED FALLS

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast by region
4.4.3. Market size and forecast by country

CHAPTER 5 IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast by region
5.2.2. Market size and forecast by country

5.3. CARDIAC CENTERS & CLINICS

5.3.1. Market size and forecast by region
5.3.2. Market size and forecast by country

5.4. AMBULATORY SURGICAL CENTERS (ASCS)

5.4.1. Market size and forecast by region
5.4.2. Market size and forecast by country

CHAPTER 6 IMPLANTABLE CARDIAC MONITOR MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends and opportunities
6.2.2. North America market size and forecast, by country
6.2.3. North America market size and forecast, by indication
6.2.4. North America market size and forecast, by end user

6.2.4.1. U.S., market size and forecast by Indication
6.2.4.2. U.S., market size and forecast, by end user
6.2.4.3. Canada market size and forecast, by indication
6.2.4.4. Canada market size and forecast, by end user
6.2.4.5. Mexico market size and forecast, by indication
6.2.4.6. Mexico market size and forecast, by end user

6.3. EUROPE

6.3.1. Key market trends and opportunities
6.3.2. Europe market size and forecast, by country
6.3.3. Europe market size and forecast, by indication
6.3.4. Europe market size and forecast, by end user

6.3.4.1. Germany market size and forecast, by indication
6.3.4.2. Germany market size and forecast, by end user
6.3.4.3. France market size and forecast, by indication
6.3.4.4. France market size and forecast, by end user
6.3.4.5. UK market size and forecast, by indication
6.3.4.6. UK market size and forecast, by end user
6.3.4.7. Italy market size and forecast, by indication
6.3.4.8. Italy market size and forecast, by end user
6.3.4.9. Spain market size and forecast, by indication
6.3.4.10. Spain market size and forecast, by end user
6.3.4.11. Switzerland market size and forecast, by indication
6.3.4.12. Switzerland market size and forecast, by end user
6.3.4.13. Rest of Europe market size and forecast, by indication
6.3.4.14. Rest of Europe market size and forecast, by end user

6.4. ASIA-PACIFIC

6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific market size and forecast, by country
6.4.3. Asia-Pacific market size and forecast, by indication
6.4.4. Asia-Pacific market size and forecast, by end user

6.4.4.1. Japan market size and forecast, by indication
6.4.4.2. Japan market size and forecast, by end user
6.4.4.3. China market size and forecast, by indication
6.4.4.4. China market size and forecast, by end user
6.4.4.5. Australia market size and forecast, by indication
6.4.4.6. Australia market size and forecast, by end user
6.4.4.7. India market size and forecast, by indication
6.4.4.8. India market size and forecast, by end user
6.4.4.9. Malaysia market size and forecast, by indication
6.4.4.10. Malaysia market size and forecast, by end user
6.4.4.11. New Zealand market size and forecast, by indication
6.4.4.12. New Zealand market size and forecast, by end user
6.4.4.13. Rest of Asia-Pacific market size and forecast, by indication
6.4.4.14. Rest of Asia-Pacific market size and forecast, by end user

6.5. LAMEA

6.5.1. Key market trends and opportunities
6.5.2. LAMEA market size and forecast, by country
6.5.3. LAMEA market size and forecast, by indication
6.5.4. LAMEA market size and forecast, by end user

6.5.4.1. Brazil market size and forecast, by indication
6.5.4.2. Brazil market size and forecast, by end user
6.5.4.3. South Africa market size and forecast, by indication
6.5.4.4. South Africa market size and forecast, by end user
6.5.4.5. Egypt market size and forecast, by indication
6.5.4.6. Egypt market size and forecast, by end user
6.5.4.7. Rest of LAMEA market size and forecast, by indication
6.5.4.8. Rest of LAMEA market size and forecast, by end user

CHAPTER 7 COMPANY PROFILE

7.1. ABBOTT LABORATORIES

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves and developments

7.2. BIOTRONIK SE & CO. KG

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Key strategic moves and developments

7.3. BOSTON SCIENTIFIC CORPORATION

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Business performance

7.4. EDWARDS LIFE SCIENCE CORPORATION

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance

7.5. GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Business performance

7.6. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance

7.7. LIVANOVA PLC (SORIN)

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance

7.8. MEDTRONIC PLC

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Business performance
7.8.5. Key strategic moves and developments

7.9. NIHON KOHDEN CORPORATION

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance

7.10. PHOENIX HEART PLLC

7.10.1. Company overview
7.10.2. Operating business segments